Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.52
0.092.62%
At close: Dec 16, 4:00 PM EST
$3.52
N/A
After Hours: 4:08 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Erasca (ERAS) stock?
You can purchase shares of Erasca (NASDAQ:ERAS) through any online brokerage.
Who are Erasca (ERAS) competitors?
Other companies in Erasca’s space includes: ARS Pharmaceuticals Inc (NASDAQ:SPRY), KalVista Pharmaceuticals Inc (NASDAQ:KALV), MoonLake Immunotherapeutics (NASDAQ:MLTX), CareDx Inc (NASDAQ:CDNA) and Day One Biopharmaceuticals Inc (NASDAQ:DAWN).
What is the forecast, or price target, for Erasca (ERAS) stock?
Erasca has a consensus price target of $5.25.
What is the current price for Erasca (ERAS)?
The stock price for Erasca (NASDAQ: ERAS) is $3.52 last updated December 16, 2025 at 4:08 PM EST.
Does Erasca (ERAS) pay a dividend?
There are no upcoming dividends for Erasca.
When is Erasca (NASDAQ:ERAS) reporting earnings?
Erasca does not have any upcoming earnings scheduled.
Is Erasca (ERAS) going to split?
There is no upcoming split for Erasca.
What sector and industry does Erasca (ERAS) operate in?
Erasca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
